Pds Planning, Inc Merck & Co., Inc. Transaction History

Pds Planning, Inc

$1.1 Billion
Q3 2024

A detailed history of Pds Planning, Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Pds Planning, Inc holds 13,518 shares of MRK stock, worth $1.35 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

13,518

Previous 13,664 1.07%

Holding current value

$1.35 Million

Previous $1.69 Million 9.23%

% of portfolio

0.14%

Previous 0.17%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	SELL	$111.15 - $128.97 $16,227 - $18,829	-146 Reduced 1.07%	13,518 $1.54 Million
Q2 2024 Aug 07, 2024	BUY	$123.8 - $132.96 $129,247 - $138,810	1,044 Added 8.27%	13,664 $1.69 Million
Q1 2024 May 01, 2024	BUY	$113.24 - $131.95 $8,606 - $10,028	76 Added 0.61%	12,620 $1.67 Million
Q4 2023 Feb 01, 2024	BUY	$100.18 - $109.02 $65,217 - $70,972	651 Added 5.47%	12,544 $1.37 Million
Q3 2023 Oct 20, 2023	BUY	$102.95 - $114.33 $4,118 - $4,573	40 Added 0.34%	11,893 $1.22 Million
Q2 2023 Jul 20, 2023	BUY	$108.61 - $118.38 $44,638 - $48,654	411 Added 3.59%	11,853 $1.37 Million
Q1 2023 May 01, 2023	BUY	$102.94 - $114.86 $383,245 - $427,623	3,723 Added 48.23%	11,442 $1.22 Million
Q4 2022 Jan 26, 2023	BUY	$87.44 - $112.11 $39,960 - $51,234	457 Added 6.29%	7,719 $0
Q3 2022 Nov 02, 2022	BUY	$84.53 - $94.96 $1,437 - $1,614	17 Added 0.23%	7,262 $625,000
Q2 2022 Jul 15, 2022	BUY	$83.49 - $94.64 $70,048 - $79,402	839 Added 13.1%	7,245 $660,000
Q1 2022 Apr 18, 2022	BUY	$73.51 - $82.4 $121,438 - $136,124	1,652 Added 34.75%	6,406 $526,000
Q4 2021 Jan 25, 2022	SELL	$72.28 - $90.54 $1,156 - $1,448	-16 Reduced 0.34%	4,754 $364,000
Q3 2021 Oct 22, 2021	SELL	$71.68 - $78.83 $6,522 - $7,173	-91 Reduced 1.87%	4,770 $358,000
Q2 2021 Jul 26, 2021	BUY	$70.31 - $77.77 $43,803 - $48,450	623 Added 14.7%	4,861 $378,000
Q1 2021 Apr 20, 2021	SELL	$68.86 - $81.11 $75,057 - $88,409	-1,090 Reduced 20.46%	4,238 $327,000
Q4 2020 Jan 21, 2021	BUY	$71.77 - $79.65 $21,818 - $24,213	304 Added 6.05%	5,328 $436,000
Q3 2020 Oct 19, 2020	BUY	$73.18 - $82.95 $8,562 - $9,705	117 Added 2.38%	5,024 $417,000
Q2 2020 Aug 11, 2020	BUY	$70.42 - $80.13 $49,927 - $56,812	709 Added 16.89%	4,907 $379,000
Q1 2020 Apr 20, 2020	BUY	$63.36 - $87.82 $21,035 - $29,156	332 Added 8.59%	4,198 $323,000
Q4 2019 Feb 07, 2020	SELL	$77.58 - $87.54 $18,153 - $20,484	-234 Reduced 5.71%	3,866 $352,000
Q3 2019 Oct 28, 2019	BUY	$76.08 - $82.93 $13,009 - $14,181	171 Added 4.35%	4,100 $345,000
Q2 2019 Aug 14, 2019	BUY	$69.84 - $81.59 $19,694 - $23,008	282 Added 7.73%	3,929 $329,000
Q1 2019 Apr 19, 2019	SELL	$69.58 - $79.36 $11,619 - $13,253	-167 Reduced 4.38%	3,647 $303,000
Q4 2018 Feb 08, 2019	BUY	$65.24 - $75.71 $13,047 - $15,141	200 Added 5.53%	3,814 $291,000
Q3 2018 Nov 02, 2018	BUY	$57.69 - $67.84 $38,017 - $44,706	659 Added 22.3%	3,614 $256,000
Q2 2018 Jul 27, 2018	BUY	$50.83 - $59.72 $150,202 - $176,472	2,955 New	2,955 $179,000

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $252B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pds Planning, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Pds Planning, Inc with notifications on news.

Account